Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerBilling CodesMicrobiology Culture and Typing ProceduresCPT cpt-87154-multiplex-molecular-identification-from-cultured-blood
    Ask Trek AI about this page

    CPT 87154: Multiplex Molecular Identification and Typing

    CPT code 87154 describes a laboratory molecular diagnostic service that uses a previously cultured blood specimen or isolate with genus and species identified to perform multiplex nucleic acid amplification and probe-based testing to determine the organism to the taxonomic level of type and to assess specific resistance markers; service type: molecular diagnostic pathogen identification and typing; typical site of service: clinical microbiology laboratory using cultured blood specimens.

    For related coverage guidance, see recent payer policy updates: Truvada (Emtricitabine and Tenofovir Disoproxil Fumarate) for HIV Prevention and Treatment, HIV/AIDS Pharmacologic Prevention and Treatment, Long-Acting Injectable Antiretroviral Agents for HIV.

    Customize your policy alerts

    Sign up for cpt 87154 policy alerts

    Get alerted when payer policies referencing 87154 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Table of contents

    Progress1 / 7

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • Facility ComparisonBeds, revenue & payer mix
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical & Coding Specifications

    Clinical Context

    A hospitalized adult patient with positive blood cultures for a Gram-negative bacillus is being evaluated for bloodstream infection. The microbiology laboratory has a previously cultured blood specimen with the organism identified to genus and species. The clinician requests advanced molecular typing to determine the organism type and to assess genetic markers of antimicrobial resistance. The laboratory performs a multiplex nucleic acid amplification test that targets at least six genetic markers to definitively type the pathogen and provide resistance information.

    Typical workflow:

    • The clinician documents the bloodstream infection and orders organism typing for therapeutic decision-making.

    • The microbiology technologist retrieves the previously cultured blood specimen or isolate and prepares nucleic acid extraction.

    • The analyst runs a multiplex amplification assay that increases DNA/RNA targets and hybridizes probes for multiple targets to identify organism type and resistance markers.

    • Results are interpreted by a laboratory physician or microbiologist, and a report is routed to the treating team to guide antimicrobial selection.

    Typical site of service: hospital clinical microbiology laboratory or independent clinical laboratory supporting inpatient care.

    Service type: molecular diagnostic test — multiplex nucleic acid amplification and probe-based target identification performed on a cultured blood specimen.

    Related CPT Codes

    CPT CodeDescriptionRelationship to This Procedure
    87154Using a previously cultured blood specimen with the culture or an isolate definitively identified to the level of genus and species, the analyst performs further testing to identify the pathogenic organism to the taxonomic level of type. The test amplifies (increases) the amount of DNA or RNA targets in the specimen, and uses probes for multiple targets (multiplex) to identify at least six targets that help specifically identify the organism and its resistance to medications.This is the primary code describing the multiplex molecular typing performed on a cultured blood specimen.
    87070Culture, blood, aerobic and anaerobic; bacterial isolation and presumptive identificationOften performed earlier in the workflow to isolate the organism from blood prior to molecular typing.
    87301Infectious agent antigen detection by immunoassay technique, multiple-step method; Streptococcus Group A (e.g., throat swab)Example of antigen detection tests that may be used for other specimen types; not directly overlapping but part of infectious disease diagnostic workflows.
    87471Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia trachomatis, amplified probe technique, single targetRepresents single-target NAATs; contrasts with the multiplex approach of 87154 and may be ordered for targeted testing.
    87598

    Related Modifiers

    8 rows

    ModifierDescriptionWhen to Use
    26Modifier 26 (Professional Component) identifies and bills only the professional portion of a split service — the physician’s interpretation, report, and medical judgment — when the technical…- Use CPT Modifier -26 when you are billing only the professional component (PC) of a split‑bill eligible service—i.e., you performed the physician interpretation, medical judgment and prepared a…
    90Modifier ‑90 (Reference/Outside Laboratory) indicates that a laboratory test was performed by an entity other than the treating or reporting provider. The American Medical Association defines…- Use CPT modifier -90 when a laboratory test is performed by an outside/reference laboratory (an entity other than the treating or reporting physician or qualified professional) and the claim needs…
    91Modifier 91 — “Repeat Clinical Diagnostic Laboratory Test” — is appended when the exact same CPT laboratory test is performed more than once for the same patient on the same day because serial,…- Use modifier 91 when the exact same CPT laboratory test is performed more than once on the same patient on the same date because serial or repeated testing is medically necessary to monitor…
    59Modifier 59 indicates a distinct procedural service when two procedures that are not normally billed together are clinically and procedurally separate. The CPT definition (as reiterated by CMS)…- Use modifier -59 to report a distinct procedural service when documentation supports that the procedure reported is not normally billed together with another service on the same day because of a…
    62Modifier 62 indicates that two surgeons function as co‑surgeons, each performing distinct parts of the same primary surgical procedure. It is appended to the primary procedure code (and any…- Use modifier -62 when two surgeons act as co‑surgeons (both primary surgeons) on a single definitive primary procedure, each performing distinct parts of the same surgical procedure (append -62 to…
    52Modifier ‑52 (Reduced Services) indicates that a service or procedure was partially reduced or omitted at the provider’s discretion, allowing reporting of the basic procedure number with a qualifier…- Use modifier -52 when a physician or qualified health professional electively reduces or omits part of a procedure or service (for example, performing fewer required views or omitting a portion of…
    22Modifier –22 (Increased Procedural Services) is used when a reported procedure is substantially more extensive than normally required. The CPT Manual and CMS state it may be appended only when the…- When to use: Append modifier -22 to a procedural CPT code when the service performed is substantially more extensive than the usual service described by that code — i.e., the procedure required…
    78CPT modifier -78 indicates an unplanned, related return to the operating or procedure room by the same provider during the global postoperative period. It is appended when treatment for a…- Use modifier -78 when an unplanned, related complication during the original procedure’s global postoperative period requires the patient to return to a formal operating or procedure room and the…

    Related Provider Taxonomies

    8 rows

    Taxonomy Code
    207RH0000X
    207L00000X
    207RP1001X
    208000000X
    363L00000X
    207RS0012X
    202C00000X
    363LA2200X

    Related ICD-10-CM Codes

    26 rows

    ICD-10-CM CodeDescription
    A40.9Streptococcal sepsis, unspecified
    A41.4Sepsis due to anaerobes
    A41.51Sepsis due to Escherichia coli [E. coli]
    A41.52Sepsis due to Pseudomonas
    A41.9Sepsis, unspecified organism
    A49.1Streptococcal infection, unspecified site
    A49.2Hemophilus influenzae infection, unspecified site
    A49.9Bacterial infection, unspecified
    B95.61Methicillin susceptible Staphylococcus aureus infection as the cause of diseases classified elsewhere
    B96.3Hemophilus influenzae [H. influenzae] as the cause of diseases classified elsewhere

    Showing 1–10 of 26

    Related Payer Policy Updates

    Specialty: Infectious Disease1 / 3

    10 rows

    PolicyPayerEffective Date
    Truvada (Emtricitabine and Tenofovir Disoproxil Fumarate) for HIV Prevention and Treatmentpremerabluecrossofwashington2026-10-01
    HIV/AIDS Pharmacologic Prevention and Treatmentpremerabluecrossofwashington2026-10-01
    Long-Acting Injectable Antiretroviral Agents for HIVColorado Rocky Mountain Health Plans2026-10-01
    B-Hemolytic Streptococcus TestingOscar Health2026-10-01
    Human Immunodeficiency Virus (HIV) — Coverage Criteria for Testing and Resistance AssaysOscar Health2026-10-01
    Hepatitis Testing (A, B, C, D) Coverage CriteriaOscar Health2026-10-01
    Lyme Disease Testing Coverage CriteriaOscar Health2026-10-01
    Pathogen Panel TestingOscar Health2026-10-01
    Diagnostic Testing of Common Sexually Transmitted InfectionsOscar Health2026-10-01
    Testing for Vector-Borne InfectionsOscar Health2026-10-01

    Related Codes

    87086-CULTURE-BACTERIAL-QUANTITATIVE-COLONY-COUNT

    CPT 87086: Urine Culture with Quantitative Colony Count

    CPT-87040-BLOOD-CULTURE-ISOLATION-PRESUMPTIVE-IDENTIFICATION

    CPT 87040: Blood Bacterial Culture with Isolation and Presumptive ID

    CPT-87045-AEROBIC-BACTERIAL-STOOL-CULTURE-SALMONELLA-SHIGELLA

    CPT 87045: Aerobic Bacterial Stool Culture for Salmonella/Shigella

    CPT-87046-AEROBIC-BACTERIAL-STOOL-CULTURE-PRESUMPTIVE-ID-NON-SALMONELLA-SHIGELLA

    CPT 87046: Aerobic Bacterial Stool Culture, Presumptive ID (non-Salmonella/Shigella)

    CPT-87070-AEROBIC-CULTURE-ISOLATION-PRESUMPTIVE-IDENTIFICATION

    CPT 87070: Aerobic Culture with Isolation and Presumptive Identification

    CPT-87071-AEROBIC-QUANTITATIVE-BACTERIAL-CULTURE-NON-URINE-BLOOD-STOOL

    CPT 87071: Quantitative Aerobic Bacterial Culture, Non-urine/blood/stool

    CPT-87073-ANAEROBIC-CULTURE-NONBLOOD-NONURINE-NONSTOOL

    CPT 87073: Anaerobic Culture, Non-Urine/Blood/Stool

    CPT-87075-ANAEROBIC-CULTURE-IDENTIFICATION-NON-BLOOD-SPECIMEN

    CPT 87075: Anaerobic Culture and Bacterial Identification (Nonblood)

    CPT-87076-ANAEROBIC-ISOLATE-DEFINITIVE-IDENTIFICATION

    CPT 87076: Anaerobic Isolate Identification to Species Level

    CPT-87077-DEFINITIVE-IDENTIFICATION-AEROBIC-ISOLATE

    CPT 87077: Definitive Identification of Aerobic Isolate

    Showing 1–10 of 30

    Frequently Asked Questions

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

    Infectious agent detection by nucleic acid (DNA or RNA), multiple organisms, amplified probe technique, each organism
    Represents multiplex organism panels and is related conceptually though 87154 is specific to typing cultured isolates.
    87449Infectious agent detection by nucleic acid (DNA or RNA); multiple organisms, real-time, each organismUsed for multiplex NAAT panels performed directly on clinical specimens; complements the cultured-specimen typing in 87154.